Taipei Medical University - WanFang Hospital
Taipei, Taiwan
NCT Number: NCT01303185
The treatment options for nail psoriasis have been limited, and the management of nail psoriasis has been challenging for physicians.To evaluate the effect of pulsed dye laser (PDL) in the treatment of nail psoriasis.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Taipei, Taiwan
Psoriatic nails of patient's right hand were treated using PDL (595 nm) .The pulsed duration is 1.5ms, the beam diameter is 7mm, and the laser energy is 8.0 to 10.0 J/cm2. The treatment course of pulse dye laser is once monthly for 6 months. Psoriatic nails of both hands are treated with Tazarotene cream for 6 months. Clinical efficacy is statistically evaluated according to Nail Psoriasis Severity Index (NAPSI) score differences between right and left hand one month after 3rd and 6th therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3rd and 6th months
Time frame: 3rd and 6th months
Taipei Medical University WanFang Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03022617
Psoriasis, Psoriasis Vulgaris
Birmingham, Alabama, United States
View Trial DetailsNCT03816917
Arthritis, Arthritis, Psoriatic
Nijmegen, Netherlands
View Trial DetailsNCT04709354
Arthritis, Arthritis, Psoriatic
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04718428
Arthritis, Arthritis, Psoriatic
Istanbul, Turkey (Türkiye)
View Trial Details